Anacor Pharmaceuticals, Inc. 4
4 · Anacor Pharmaceuticals, Inc. · Filed Apr 17, 2015
Insider Transaction Report
Form 4
Plattner Jacob j
Senior VP Research
Transactions
- Sale
Common Stock
2015-04-15$62.81/sh−8,920$560,265→ 26,760 total(indirect: See Footnote)
Holdings
- 5,020
Common Stock
Footnotes (2)
- [F1]This sale was effected pursuant to a pre-existing Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]These shares are held by Jacob & Jeanne Plattner Trust U/A 7/17/04, Jacob Plattner & Jeanne Plattner, Trustees.